Development of cutaneous squamous cell carcinoma during pembrolizumab therapy.
Mizutani K, Nakanishi T, Ikejiri M, Yuasa H, Matsushima Y, Kondo M, Nakai Y, Habe K, Nakatani K, Yamanaka K.
Mizutani K, et al. Among authors: kondo m.
J Dermatol. 2021 Jan;48(1):e7-e8. doi: 10.1111/1346-8138.15614. Epub 2020 Sep 17.
J Dermatol. 2021.
PMID: 32940367
No abstract available.